[Acupuncture therapy in the treatment of patients with bronchial asthma].

[Characteristics of cyclic nucleotide metabolism in the leukocytes of patients with bronchial asthma]. Ter Arkh (1980) 0.77

[Disturbance of apoptosis of peripheral blood lymphocytes in different variants of bronchial asthma]. Ter Arkh (2008) 0.77

[Bronchial asthma and obesity: common mechanisms]. Klin Med (Mosk) (2012) 0.76

Mechanisms of changes in adrenoreceptor activity of leukocytes during immune stimulation. Hum Physiol (1985) 0.76

[The role of serotonin, histamine and the kallikrein-kinin system in the pathogenesis of asphyxic attacks in bronchial asthma]. Ter Arkh (1992) 0.75

[Heart and respiratory rates with regard to the degree of success in performing mental tasks]. Fiziol Cheloveka (1986) 0.75

[The effect of adequate therapy on the indices of external respiratory function in patients with arterial hypertension combined with obstructive lung diseases]. Ter Arkh (1990) 0.75

[An analysis of the acupuncture treatment results in bronchial asthma patients]. Vopr Kurortol Fizioter Lech Fiz Kult (1995) 0.75

[Clinical picture, diagnosis and treatment of patients with bronchial asthma and intolerance for acetylsalicylic acid]. Ter Arkh (1988) 0.75

[Current views on the role of disorders of hormonal regulation in the development of altered sensitivity and reactivity of the bronchi]. Vestn Akad Med Nauk SSSR (1989) 0.75

[The therapeutic potentials of Berotec-100 in bronchial asthma patients]. Klin Med (Mosk) (1998) 0.75

[The clinical pharmacology of drugs for the therapy of the broncho-obstructive syndrome]. Farmakol Toksikol (1990) 0.75

[Pulmonary diffusing capacity in patients with chronic renal failure treated by hemodialysis]. Klin Med (Mosk) (1992) 0.75

[The modern concept of the diagnosis and treatment of bronchial asthma (a lecture)]. Lik Sprava (1992) 0.75

[Features of erythrocyte aggregation in various forms of bronchial asthma]. Vrach Delo (1989) 0.75

[Effect of medications and acupuncture on indicators of a bioenergetigram of bronchial asthma patients]. Ter Arkh (2003) 0.75

[Atopic bronchial asthma as pathology of the membrane-receptor complex]. Vestn Akad Med Nauk SSSR (1989) 0.75

[The potentials of a unified polyclinic-hospital system in raising the quality of the diagnosis and the efficacy of the differentiated therapy of bronchial asthma patients]. Ter Arkh (1990) 0.75

[The effect of morphine and naloxone on histamine- and serotonin-induced bronchospasms]. Farmakol Toksikol (1990) 0.75

[Membranoreceptor disorders in the pathogenesis of bronchial asthma]. Ter Arkh (1991) 0.75

[Role of biological defects in formation and development of bronchial asthma and potentialities of premorbid diagnosis]. Vestn Ross Akad Med Nauk (2000) 0.75

[Change in human attention parameters during reduced motor activity (hypokinesia)]. Dokl Akad Nauk SSSR (1976) 0.75

[Various unsolved problems of present-day internal medicine]. Sov Med (1986) 0.75

[Features of absorption of cortisol by peripheral blood cells in patients with bronchial asthma]. Ter Arkh (1989) 0.75

[Detection of disorders in lymphocyte adrenoreactivity in bronchial asthma]. Lab Delo (1981) 0.75

[Mechanisms of asthma of effort]. Ter Arkh (1989) 0.75

[Clinico-immunologic heterogeneity in patients with bronchial asthma]. Klin Med (Mosk) (1987) 0.75

[The efficacy of the magnesium sulfate aerosol treatment of bronchial asthma patients]. Ter Arkh (1997) 0.75

[Plasma leptin level in patients with bronchial asthma]. Klin Med (Mosk) (2009) 0.75

[The experience of using ergotherapy in patients with bronchial asthma due to physical effort]. Vopr Kurortol Fizioter Lech Fiz Kult (1991) 0.75

[Comparative trial of 3-day azithromycin versus 10-day coamoxilav course efficacy in acute sinusitis]. Ter Arkh (1998) 0.75

[Reasons for altered leukocyte adrenoreactivity in bronchial asthma]. Ter Arkh (1982) 0.75

[The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis]. Ter Arkh (1997) 0.75

[Decreased ceruloplasmin levels in the blood serum--an index of atopy in bronchial asthma]. Ter Arkh (1984) 0.75

[Treatment of patients with bronchial asthma by voluntary changes in the pattern of respiration]. Klin Med (Mosk) (1991) 0.75

[Role of magnesium and calcium ions in the pathogenesis of bronchial asthma]. Klin Med (Mosk) (1994) 0.75

[The therapeutic potentials of Ditec in bronchial asthma patients]. Ter Arkh (1995) 0.75

[Pre-asthma, signs which threaten the development of bronchial asthma]. Ter Arkh (1981) 0.75

[Erythrocyte insulin-reactive system and carbohydrate metabolism in bronchial asthma]. Ter Arkh (2002) 0.75

[Gustatory sensitivity to sodium chloride and potassium chloride and certain parameters of sodium metabolism in patients with bronchial asthma]. Klin Med (Mosk) (2008) 0.75

The study of pathogenetic basis of asthma using biostatistic models. Allergol Immunopathol (Madr) (1988) 0.75

[Surface architectonics and cytoskeleton of erythrocytes and their modulation by adrenergic agents in patients with bronchial asthma]. Ter Arkh (2004) 0.75

[The role of disorders in the homeostasis of divalent cations in the pathogenesis and clinical picture of bronchial asthma]. Ter Arkh (1994) 0.75

[The role of disorders of copper and zinc homeostasis in the pathogenesis of bronchial asthma]. Ter Arkh (1989) 0.75

[Errors in the diagnosis of acute diffuse glomerulonephritis in elderly patients]. Sov Med (1971) 0.75

[Effect of adrenergic and histaminergic disorders on the subclinical course of atopic bronchial asthma]. Klin Med (Mosk) (2003) 0.75

[Bronchial nonspecific reactivity in patients with bronchial asthma and in the preasthmatic state and its alteration under the influence of acupuncture]. Ter Arkh (1995) 0.75

[Role of disorders of cyclic adenosine-3',5'--monophosphate (cAMP) in the pathogenesis of bronchial asthma]. Ter Arkh (1977) 0.75

[Mechanisms of the change in leukocyte adrenoreactivity during immune stimulation]. Fiziol Cheloveka (1985) 0.75

[Markedness of the immunopathological component and its detection in infectious-allergic bronchial asthma]. Ter Arkh (1975) 0.75

[Problems of causality in internal pathology]. Ter Arkh (1987) 0.75

The specific binding of beta-adrenergic ligands and morphofunctional properties of erythrocytes in bronchial asthma. J Investig Allergol Clin Immunol (1994) 0.75

[Follow-up of patients with neurosis-like stuttering]. Zh Nevropatol Psikhiatr Im S S Korsakova (1981) 0.75

[Epifamine efficacy in aspirin bronchial asthma]. Klin Med (Mosk) (2001) 0.75

[Antibiotics in emergency medicine]. Anesteziol Reanimatol (1997) 0.75

[Effects of magnesium sulfate aerosol on indices of external respiration in patients with bronchial asthma]. Klin Med (Mosk) (1990) 0.75

[Role of eosinophils in the pathogenesis of bronchial asthma]. Ter Arkh (1990) 0.75

[Respiration and bronchial patency in patients with bronchial asthma during physical exercise]. Klin Med (Mosk) (1990) 0.75

[Membrane receptor disorders in bronchial asthma]. Ter Arkh (1999) 0.75

[The therapeutic potentials of magnesium sulfate in bronchial asthma]. Ter Arkh (1991) 0.75

[Quality of life and characteristics of the external respiration function in patients with bronchial asthma]. Ter Arkh (2001) 0.75

[Level of specific binding of beta-adrenergic ligands and the morphofunctional properties of erythrocytes in bronchial asthma]. Ter Arkh (1988) 0.75

[Bronchial reactivity characteristics in EEG variants in bronchial asthma patients]. Klin Med (Mosk) (1995) 0.75

[Role of erythrocytes in the pathogenesis of bronchial asthma--nontraditional aspects]. Ter Arkh (1990) 0.75

[Disorders of cellular regulation systems as a basis for changed bronchial reactivity in bronchial asthma]. Ter Arkh (1984) 0.75

[Evaluating the activity of the apoptosis-regulating genes from Bcl-2, Bax expression, and caspase-3 activity in bronchial epithelial cells in patients with asthma]. Arkh Patol (2011) 0.75

[Functional state of external respiratory system in patients with 2d stage chronic pneumonia and bronchial asthma]. Ter Arkh (1976) 0.75

[Various metabolic systems of lymphocytes in bronchial asthma]. Ter Arkh (1986) 0.75

[Membrane-receptor disorders in adrenergic and histaminergic systems under peroxide exposure in bronchial asthma patients]. Ter Arkh (2000) 0.75

[Influence of berotec inhalations on pulmonary gas exchange in patients with bronchial asthma]. Ter Arkh (2000) 0.75

[Phenomenon of hyperexpression of ribosomic cistrons in bone marrow hemopoietic elements in bronchial asthma]. Ter Arkh (2004) 0.75

[The correction of biological defects in bronchial asthma patients by the methods of Chinese medicine]. Ter Arkh (1996) 0.75

[The role of microelements in the pathogenesis and clinical course of bronchial asthma]. Klin Med (Mosk) (1989) 0.75

[The results of the dynamic observation of bronchial hyperreactivity in risk-group subjects and in bronchial asthma patients. Some corrective procedures]. Ter Arkh (1991) 0.75

Some physiological mechanisms of disturbances of the blood gas composition associated with altered bronchial patency. Hum Physiol (1983) 0.75

[The effect of exercise on the content of biogenic amines and acetylcholine of the blood in bronchial asthma patients]. Ter Arkh (1989) 0.75

[Chronoprevention and chronotherapy of bronchial asthma]. Ter Arkh (1987) 0.75

[Magnesium sulfate in management of bronchial asthma]. Klin Med (Mosk) (1996) 0.75

[The clinico-functional effectiveness of calcium antagonists in correcting the bronchial hyperreactivity of bronchial asthma patients]. Ter Arkh (1990) 0.75

[Clinical and functional characteristics of the preasthmatic state]. Klin Med (Mosk) (1982) 0.75

[Peculiarities of cell reception in bronchial asthma patients with bronchial hyperreactivity to hyperosmolar provocation]. Ter Arkh (2000) 0.75

[Functional signs of a threatening onset of bronchial asthma]. Ter Arkh (1975) 0.75

[Bronchoobstructive syndrome in bronchoectasias]. Ter Arkh (2004) 0.75

[Relationship between temperature of inhaled air during respiratory load and indicators of external respiration]. Fiziol Cheloveka (1991) 0.75

[Antibacterial therapy of sinusitis]. Antibiot Khimioter (1999) 0.75

[Pathogenesis and treatment of bronchial asthma]. Klin Med (Mosk) (1977) 0.75